Literature DB >> 12572681

Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures.

José Tomás Egaña1, Cristian Zambrano, Marco Tulio Nuñez, Christian Gonzalez-Billault, Ricardo B Maccioni.   

Abstract

Oxidative stress phenomena have been related with the onset of neurodegenerative diseases. Particularly in Alzheimer Disease (AD), oxygen reactive species (ROS) and its derivatives can be found in brain samples of postmortem AD patients. However, the mechanisms by which oxygen reactive species can alter neuronal function are still not elucidated. There is a growing amount of evidence pointing to a role for mitochondrial damage as the source of free radicals involved in oxidative stress. Among the species that participate in the production of oxygen reactive radicals, transition metals are one of the most important. Several reports have implicated the involvement of redox-active metals with the onset of different neurodegenerative diseases such as Alzheimer's Disease (AD), Progressive Supranuclear Palsy (PSP), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD). On the other hand, our previous studies have indicated that A beta-induced deregulation of the protein kinase Cdk5 associated with tau protein hyperphosphorylation constitute a critical pathway toward neurodegeneration. In the current paper we have shown that iron induces an imbalance in the function of Cdk5/p25 system of hippocampal neurons, resulting in a marked decrease in tau phosphorylation at the typical Alzheimer's epitopes. The loss of phosphorylated tau epitopes correlated with an increase in 4-hydroxy-nonenal (HNE) adducts revealing damage by oxidative stress. This effects on tau phosphorylation patterns seems to be a consequence of a decrease in the Cdk5/p25 complex activity that appears to result from a depletion of the activator p25, a mechanism in which calcium transients could be implicated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12572681     DOI: 10.1023/a:1020727218493

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  29 in total

1.  Early post-natal iron administration induces astroglial response in the brain of adult and aged rats.

Authors:  Liana Lisboa Fernandez; Maria Noêmia Martins de Lima; Felipe Scalco; Gustavo Vedana; Clívia Miwa; Arlete Hilbig; Mônica Vianna; Nadja Schröder
Journal:  Neurotox Res       Date:  2010-12-17       Impact factor: 3.911

Review 2.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Oxidative stress and 17-alpha- and 17-beta-estradiol modulate neurofilaments differently.

Authors:  Keith Chiasson; Vicky Lahaie-Collins; Julie Bournival; Benoit Delapierre; Sylvie Gélinas; Maria-Grazia Martinoli
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

Authors:  Paul J Derry; Muralidhar L Hegde; George R Jackson; Rakez Kayed; James M Tour; Ah-Lim Tsai; Thomas A Kent
Journal:  Prog Neurobiol       Date:  2019-10-08       Impact factor: 11.685

Review 5.  New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases.

Authors:  Na Zhang; Xiaoqi Yu; Junxia Xie; Huamin Xu
Journal:  Mol Neurobiol       Date:  2021-01-28       Impact factor: 5.590

Review 6.  Therapeutic strategies for tauopathies and drug repurposing as a potential approach.

Authors:  Majedul Islam; Fengyun Shen; Deepika Regmi; Deguo Du
Journal:  Biochem Pharmacol       Date:  2022-02-24       Impact factor: 6.100

7.  Getting the iron out: phlebotomy for Alzheimer's disease?

Authors:  Barney E Dwyer; Leo R Zacharski; Dominic J Balestra; Alan J Lerner; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Med Hypotheses       Date:  2009-02-04       Impact factor: 1.538

8.  Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.

Authors:  Shalini S Rao; Larissa Lago; Irene Volitakis; Jay J Shukla; Gawain McColl; David I Finkelstein; Paul A Adlard
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

9.  Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration.

Authors:  Eng-Tat Ang; Yee-Kit Tai; Shun-Qiang Lo; Raymond Seet; Tuck-Wah Soong
Journal:  Front Aging Neurosci       Date:  2010-07-21       Impact factor: 5.750

10.  Modulation of iron metabolism in aging and in Alzheimer's disease: relevance of the choroid plexus.

Authors:  Sandro D Mesquita; Ana C Ferreira; João C Sousa; Nadine C Santos; Margarida Correia-Neves; Nuno Sousa; Joana A Palha; Fernanda Marques
Journal:  Front Cell Neurosci       Date:  2012-05-22       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.